News
Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback